217 related articles for article (PubMed ID: 30105252)
1. Association between Participants' Characteristics, Patient-Reported Outcomes, and Clinical Outcomes in Youth with Sickle Cell Disease.
Badawy SM; Barrera L; Cai S; Thompson AA
Biomed Res Int; 2018; 2018():8296139. PubMed ID: 30105252
[TBL] [Abstract][Full Text] [Related]
2. Healthcare utilization and hydroxyurea adherence in youth with sickle cell disease.
Badawy SM; Thompson AA; Holl JL; Penedo FJ; Liem RI
Pediatr Hematol Oncol; 2018; 35(5-6):297-308. PubMed ID: 30636474
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease.
Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27896936
[TBL] [Abstract][Full Text] [Related]
4. Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.
Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
Health Qual Life Outcomes; 2017 Jul; 15(1):136. PubMed ID: 28679417
[TBL] [Abstract][Full Text] [Related]
5. Beliefs about hydroxyurea in youth with sickle cell disease.
Badawy SM; Thompson AA; Liem RI
Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):142-148. PubMed ID: 29397333
[TBL] [Abstract][Full Text] [Related]
6. Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease.
Badawy SM; Thompson AA; Penedo FJ; Lai JS; Rychlik K; Liem RI
Eur J Haematol; 2017 Jun; 98(6):608-614. PubMed ID: 28306171
[TBL] [Abstract][Full Text] [Related]
7. Higher hydroxyurea adherence among young adults with sickle cell disease compared to children and adolescents.
Reddy PS; Cai SW; Barrera L; King K; Badawy SM
Ann Med; 2022 Dec; 54(1):683-693. PubMed ID: 35234095
[TBL] [Abstract][Full Text] [Related]
8. A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study.
Creary S; Chisolm D; Stanek J; Hankins J; O'Brien SH
JMIR Mhealth Uhealth; 2019 Aug; 7(8):e13452. PubMed ID: 31397291
[TBL] [Abstract][Full Text] [Related]
9. Initial Evaluation of the Pediatric PROMIS® Health Domains in Children and Adolescents With Sickle Cell Disease.
Dampier C; Barry V; Gross HE; Lui Y; Thornburg CD; DeWalt DA; Reeve BB
Pediatr Blood Cancer; 2016 Jun; 63(6):1031-7. PubMed ID: 26895143
[TBL] [Abstract][Full Text] [Related]
10. Examining Mental Health, Education, Employment, and Pain in Sickle Cell Disease.
Harris KM; Preiss L; Varughese T; Bauer A; Calhoun CL; Treadwell M; Masese R; Hankins JS; Hussain FA; Glassberg J; Melvin CL; Gibson R; King AA;
JAMA Netw Open; 2023 May; 6(5):e2314070. PubMed ID: 37200033
[TBL] [Abstract][Full Text] [Related]
11. Adherence to Hydroxyurea and Patients' Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study.
Madkhali MA; Abusageah F; Hakami F; Zogel B; Hakami KM; Alfaifi S; Alhazmi E; Zaalah S; Trabi S; Alhazmi AH; Mohrag M; Malhan H
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256385
[No Abstract] [Full Text] [Related]
12. Sex-based differences in the manifestations and complications of sickle cell disease: Report from the Sickle Cell Disease Implementation Consortium.
Masese RV; Bulgin D; Knisely MR; Preiss L; Stevenson E; Hankins JS; Treadwell MJ; King AA; Gordeuk VR; Kanter J; Gibson R; Glassberg JA; Tanabe P; Shah N;
PLoS One; 2021; 16(10):e0258638. PubMed ID: 34714833
[TBL] [Abstract][Full Text] [Related]
13. Neuropathic pain is associated with poor health-related quality of life in adolescents with sickle cell disease: A preliminary report.
Román ME; Highland J; Retherford D; Pan AY; Panepinto JA; Brandow AM
Pediatr Blood Cancer; 2020 Dec; 67(12):e28698. PubMed ID: 33034107
[TBL] [Abstract][Full Text] [Related]
14. Differences in quality of life between pediatric sickle cell patients who used hydroxyurea and those who did not.
Nwenyi E; Leafman J; Mathieson K; Ezeobah N
Int J Health Care Qual Assur; 2014; 27(6):468-81. PubMed ID: 25115050
[TBL] [Abstract][Full Text] [Related]
15. Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach.
Alberts NM; Badawy SM; Hodges J; Estepp JH; Nwosu C; Khan H; Smeltzer MP; Homayouni R; Norell S; Klesges L; Porter JS; Hankins JS
JMIR Mhealth Uhealth; 2020 May; 8(5):e14884. PubMed ID: 32383683
[TBL] [Abstract][Full Text] [Related]
16. Mobile health intervention for youth with sickle cell disease: Impact on adherence, disease knowledge, and quality of life.
Anderson LM; Leonard S; Jonassaint J; Lunyera J; Bonner M; Shah N
Pediatr Blood Cancer; 2018 Aug; 65(8):e27081. PubMed ID: 29693797
[TBL] [Abstract][Full Text] [Related]
17. Assessment of menstrual health in adolescent and young adults with sickle cell disease.
Notice B; Soffer E; Tickle K; Xiang Y; Gee BE; Sidonio RF; Sokkary N; Batsuli G
Pediatr Blood Cancer; 2024 Jan; 71(1):e30727. PubMed ID: 37845801
[TBL] [Abstract][Full Text] [Related]
18. Health-Related Quality of Life and Adherence to Hydroxyurea and Other Disease-Modifying Therapies among Individuals with Sickle Cell Disease: A Systematic Review.
Yang M; Elmuti L; Badawy SM
Biomed Res Int; 2022; 2022():2122056. PubMed ID: 35898672
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive and emotional factors predict pain-related healthcare utilization in children with sickle cell disease.
Hardy SJ; Williams Z; Berger C; Griffin D; Weisman H; Liang H; Darbari DS
Pediatr Blood Cancer; 2023 Jun; 70(6):e30346. PubMed ID: 37026487
[TBL] [Abstract][Full Text] [Related]
20. Measuring hydroxyurea adherence by pharmacy and laboratory data compared with video observation in children with sickle cell disease.
Creary S; Chisolm D; Stanek J; Neville K; Garg U; Hankins JS; O'Brien SH
Pediatr Blood Cancer; 2020 Aug; 67(8):e28250. PubMed ID: 32386106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
